There's never been a better time to Buy BC and support local growers, producers and the food we love right here in BC.  Explore Buy BC products
Government of B.C. Government of B.C. Government of B.C. Government of B.C. BC Gov News
  • Skip to main content
  • Skip to footer
Live Webcast
  • News  
  • News  
  • By Ministry
    • Office of the Premier
    • Agriculture and Food
    • Attorney General
    • Children and Family Development
    • Citizens' Services
    • Education and Child Care
    • Emergency Management and Climate Readiness
    • Energy and Climate Solutions
    • Environment and Parks
    • Finance
    • Forests
    • Health
    • Housing and Municipal Affairs
    • Indigenous Relations and Reconciliation
    • Infrastructure
    • Intergovernmental Relations Secretariat
    • Jobs, Economic Development and Innovation
    • Labour
    • Mining and Critical Minerals
    • Post-Secondary Education and Future Skills
    • Public Safety and Solicitor General
    • Social Development and Poverty Reduction
    • Tourism, Arts, Culture and Sport
    • Transportation and Transit
    • Water, Land and Resource Stewardship
  • Subscribe
Live Webcast
By Ministry
  • Office of the Premier
  • Agriculture and Food
  • Attorney General
  • Children and Family Development
  • Citizens' Services
  • Education and Child Care
  • Emergency Management and Climate Readiness
  • Energy and Climate Solutions
  • Environment and Parks
  • Finance
  • Forests
  • Health
  • Housing and Municipal Affairs
  • Indigenous Relations and Reconciliation
  • Infrastructure
  • Intergovernmental Relations Secretariat
  • Jobs, Economic Development and Innovation
  • Labour
  • Mining and Critical Minerals
  • Post-Secondary Education and Future Skills
  • Public Safety and Solicitor General
  • Social Development and Poverty Reduction
  • Tourism, Arts, Culture and Sport
  • Transportation and Transit
  • Water, Land and Resource Stewardship

Health

PharmaCare reviews class of diabetes drugs, saves millions

Share

More from this Ministry
Honourable Josie Osborne

Honourable Josie Osborne

Honourable Josie Osborne

Read Bio

Contact

Email: HLTH.Minister@gov.bc.ca

close menu Health

Streamlined process cuts wait times, bringing more U.S. nurses to B.C.

May 12, 2025 12:34 PM
Nurse attending to a patient. Text: Record number of US nurses coming to BC to work.
New streamlined credential recognition means nurses from the United States can now work in B.C. much quicker, with registrations taking only a few days, compared to the previous average as long as four months.
  Read More

B.C. invests in planning for northern youth support centre

May 7, 2025 10:30 AM
ALL NEWS FROM THIS MINISTRY
More from this Ministry
  • Factsheets & Opinion Editorials
  • Search News
  • Minister's Bio
  • Skip to main content
  • Skip to footer
Print

Health

British Columbia News

PharmaCare reviews class of diabetes drugs, saves millions

https://news.gov.bc.ca/07339

Share

News Release

Victoria
Thursday, November 6, 2014 10:05 AM

Share

News Release

Victoria

Thursday, November 6, 2014 10:05 AM

More from this Ministry

  • Factsheets
  • Ministry Website
  • Ministry Photos
  • Ministry Videos

Featured Topics

  • Accessing Health Care
  • Health Connect Registry
  • Health & Drug Coverage
  • Building better mental health and addictions care
  • HelpStartsHere

Featured Services

  • HealthLink BC
  • Medical Services Plan
  • BC PharmaCare

PharmaCare, B.C.’s public drug plan, stands to save millions of dollars after a review of evidence lead the plan to change its coverage of a class of diabetes drugs called dipeptidyl peptidase-4 (DPP-4) inhibitor drugs.

After a thorough therapeutic review, PharmaCare now covers two DPP-4 inhibitor drugs, linagliptin and saxagliptin.  PharmaCare no longer covers a third, more expensive drug, sitagliptin (Januvia.) These drugs are used for Type 2 diabetics, when insulin and other first-line treatments have not worked. Experts agree all three drugs are equally effective and safe; sitagliptin (Januvia) products may cost up to 35% more than the two DPP-4 inhibitor drugs PharmaCare now covers.

“This decision is in line with PharmaCare’s efforts to reduce drug costs while increasing coverage. PharmaCare is choosing to cover the two more economical options, to ensure value for money for taxpayers. This decision will save PharmaCare millions of dollars a year, in order to fund other drugs and programs. “

PharmaCare used to be one of the fastest growing areas of the health care budget; however, the ministry has been able to reduce PharmaCare’s budget by more than 8% this fiscal year, even as the plan covered more drugs and therapies.

For patients on sitagliptin (Januvia), PharmaCare is allowing six months for them to transition to one of the two covered DPP-4 drugs. The transition period began Aug. 5, 2014, and ends Feb. 5, 2015. This allows patients to use any drug supply they may have, and to have their prescription adjusted at their next regular doctor visit.

In making this decision, PharmaCare sought advice from the province’s expert Drug Benefit Council, engaged drug manufacturers, and consulted with endocrinologists, patient advocacy groups, Doctors of B.C. and other stakeholders. 

Patients who are unable to tolerate linagliptin or saxagliptin may apply for exceptional coverage for sitagliptin (Januvia) through PharmaCare’s Special Authority process.

This type of switch from one drug to another within a class of drugs is called therapeutic substitution. It is considered a safe and effective practice, which B.C. has used for a number of years. Since 2008, therapeutic adaptation (substitution) is also something pharmacists do routinely in B.C. for certain drug classes, as authorized by the College of Pharmacists of B.C.

Scientific evaluations of B.C.’s policies on therapeutic substitution have been published in the New England Journal of Medicine and the Canadian Medical Association Journal. These studies found substitution was safe for patients and saved money. Harvard researchers found these policies did not have negative patient or health system effects, but resulted in savings of millions of dollars.

Nova Scotia, Saskatchewan and Quebec also use therapeutic substitution in their public drug plans. Many other countries use therapeutic substitution, including Australia, Belgium, Denmark, Germany, Italy, New Zealand, the Netherlands, Portugal, Spain, Sweden and various private health-care plans in the United States.

Learn more:

To read the drug coverage decision summary, please visit: http://www.health.gov.bc.ca/pharmacare/pdf/DDS-0054.pdf

To learn more about PharmaCare, please visit: http://www.health.gov.bc.ca/pharmacare/

Media Contacts:

Kristy Anderson
Media Relations Manager
Ministry of Health
250 952-1887 (media line)

https://news.gov.bc.ca/07339

Related Articles

Streamlined process cuts wait times, bringing more U.S. nurses to B.C.

May 12, 2025 12:34 PM

B.C. invests in planning for northern youth support centre

May 7, 2025 10:30 AM

Minister’s, parliamentary secretary’s statement on National Nursing Week, International Nurses Day

May 12, 2025 11:45 AM
BC Gov News

Connect with the Ministry

Photos

View the Ministry's latest photos on Flickr.

Videos

Watch the Ministry's latest videos on YouTube.

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

Government of B.C. Government of B.C.

We can help in over 220 languages and through other accessible options.   Call, email or text us, or find a service centre.

Connect with Us

  • Subscribe
  • Social and RSS

More Info

  • BC Gov
  • Disclaimer
  • Privacy
  • Accessibility
  • Copyright
  • Contact Us

© 2025 Government of British Columbia